Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection

Transplantation

Volumn 61, Issue 5, 1996, Pages 722-729

  Danovitch, Gabriel ^a,b   Deierhoi, Mark ^a   Ferguson, Ronald ^a   Linna, Juhani ^a   Monroe, Scott ^a   Tomlanovich, Stephen ^a  

^a UCLA School of Medicine ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; PREDNISONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT PLANNING;

EID: 0029922910     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603150-00009     Document Type: Article

References (20)

1. Gjertson DW. Survival trends in long-term first cadaver donor kidney transplants. In: Terasaki PI, ed. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 225.
2. Lindholm A, Albrechtsen D, Tufveson G, Karlberg I, Persson NH, Groth CG. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. Transplantation 1992; 54: 624.
3. Koyama H, Cecka JM. Rejection episodes. In: Terasaki PI, ed. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 391.
4. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56: 307.
5. Allison AC, Eugui EM. Mycophenolate mofetil, a rationally designed immunosuppressive drug. Clin Transpl 1993; 7: 96.
6. Morris RE, Wang J, Blum JR, et al. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant Proc 1991; 23: 19.
7. Morris RE, Hoyt EG, Murphy MP, Eugui EM, Allison AC. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transplant Proc 1990; 22: 1659.
8. Bechstein WO, Schilling M, Steele DM, Hullet DA, Sollinger HW. RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival. Transplant Proc 1993; 25 (1 Pt 1): 702.
9. Platz KP, Sollinger HW, Hullett DA, Eckhoff DE, Eugui EM, Allison AC. RS-61443 - a new, potent immunosuppressive agent. Transplantation 1991; 51: 27.
10. Platz KP, Bechstein WO, Eckhoff DE, Suzuki Y, Sollinger HW. RS-61443 reverses acute allograft rejection in dogs. Surgery 1991; 110: 736.
11. Sollinger HW, U. S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
12. Sollinger HW, Belzer FO, Deierhoi MH, et al. RS-61443 (mycophenolate mofetil): a multicenter study for refractory kidney transplant rejection. Ann Surg 1992; 216: 513.
13. Sollinger HW, Deierhoi MH, Belzer FO, Diethelm AG, Kauffman RS. RS-61443: a phase I clinical trial and pilot rescue study. Transplantation 1992; 53: 428.
14. Brunier H, Whitehead J. PEST planning and evaluation of sequential clinical trials. Version 3, Manual and computer package. Reading, PA: Reading University, 1993.
15. Whitehead J. The design and analysis of sequential clinical trials. West Sussex, England: Ellis Horwood Limited, 1992.
16. Fleiss J. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley and Sons, 1981.
17. Gulanikar AC, MacDonald AS, Sungurtekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
18. Almond PS, Matas AJ, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
19. Tesi RJ, Henry ML, Elkhammas EA, Ferguson RM. Predictors of long-term primary cadaveric renal transplant survival. Clin Transpl 1993; 7: 345.
20. Salmela K, Kyllönen L, Eklund B, Isoniemi H, Hockerstedt K, Ahonen J. The value of repeated renal transplantations. Transplantation 1990; 50: 984.